Volume-2 ,Issue-4, April-2026

In the pharmaceutical sciences, three-dimensional (3D) printing has become a game-changing technology that makes it possible to create customized drug delivery systems, adaptable manufacturing procedures, and novel dosage forms. Pharmaceutical additive manufacturing has advanced quickly in recent years due to increased research interest, but the area is still quite interdisciplinary and dispersed, requiring a methodical assessment of global research trends. In order to examine publication growth, influential authors, institutions, nations, collaboration networks, and subject change, this study offers a thorough bibliometric review of 3D printing in pharmaceuticals. Bibliometric tools like VOSviewer, Biblioshiny, and CiteSpace were used to examine the bibliographic data that was gathered from important scientific databases including Scopus, Web of Science, and PubMed. The findings show a consistent rise in research production, especially after 2015, with major contributions from developed nations and growing international cooperation. Early feasibility and formulation studies have given way to more sophisticated uses, such as point-of-care medication manufacture, polypills, modified-release dosage forms, and personalized medicine, according to keyword and theme analysis. Large-scale industrial use of 3D printing technologies including fused deposition modeling, stereolithography, binder jetting, and selective laser sintering is still hampered by issues with cost, scalability, quality control, and regulatory frameworks. Overall, this review outlines important research gaps and future initiatives necessary for the effective clinical and commercial translation of pharmaceutical 3D printing while highlighting the field's changing research landscape.

Keyword: 3D printing; Additive manufacturing; Pharmaceutical sciences; Personalized medicine; Drug delivery systems; Bibliometric analysis; Regulatory challenges